Jorge Arellano

Healthcare Policy Changes in Osteoporosis Can Improve Outcomes and Reduce Costs in the United States

E. Michael Lewiecki, Jesse D. Ortendahl, J. Vanderpuye-Orgle et al. · JBMR Plus · 2019 · 229 citations · Full text

Medicine, Health Policy, Orthopedic Surgery +15

Safety of long-term denosumab therapy: results from the open label extension phase of two phase 3 studies in patients with metastatic breast and prostate cancer

Alison Stopeck, Karim Fizazi, Jean-Jacques Body et al. · Supportive Care in Cancer · 2015 · 190 citations · Full text

Medicine, Oncology, Pharmacotherapy +16

Updated Cost-effectiveness Analysis of Evolocumab in Patients With Very High-risk Atherosclerotic Cardiovascular Disease

Gregg C. Fonarow, Ben van Hout, Guillermo Villa et al. · JAMA Cardiology · 2019 · 88 citations · Full text

Pharmacy, Cardiology, Pharmacoeconomics +17

Prevalence of bone metastases and bone-targeting agent use among solid tumor patients in the United States

Michael Wade, Rohini K. Hernandez, Avanti Adhia et al. · Clinical Epidemiology · 2015 · 69 citations · Full text

Medicine, Oncology, Orthopedic Surgery +16

High frequency of association of rheumatic/autoimmune diseases and untreated male hypogonadism with severe testicular dysfunction

Francisco Javier Jiménez-Balderas, Rosario Tapia-Serrano, Ma. Eugenia Fonseca et al. · Arthritis Research & Therapy · 2001 · 61 citations · Full text

Medicine, Endocrinology, Genetics +17